Top Back to top

Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Paediatric Multiple Sclerosis

Study number:
Type of transplant:
Short title:
Study status:
Data Collection
Deadline for data collection:
Study design:
Open, multicentre retrospective study
Primary objective:
To describe the efficacy of aHSCT for juvenile multiple sclerosis in children and adolescents.
Key inclusion criteria:
MS patients treated with autologous HSCT before 18y at time of transplant
Principal investigator:
J Burman, K Kirgizov
Principal investigator email:
EBMT Study coordinator:
Manuela Badoglio

Need help?

The personal data provided will be processed according to the General Data Protection Regulation (GDPR 2016/679 ) and incorporated to a file property of EBMT which will be allocated in the EEA (European Economic Area) or in countries that are provided with the same level of protection for privacy such as countries that adhere to EU-US and Swiss-US Privacy Shield Frameworks.
Data Subjects have the right of access to his or her data and the right to rectification of any inaccurate or incomplete personal data. The Data Subject also has the right to withdraw consent, this wish will be respected, and the personal will no longer be made available. If the processing operation is unlawful the Data Subject has the right to request deletion of that data. Please write to